ArticleFrontiers in immunology2025

Case Report: Ivonescimab in EGFR-mutant lung cancer with baseline malignant pleural effusion and acquired complex resistance.

Zeming Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.